Why Walgreens Q1 Is Underwhelming
Walgreens reported disappointing fiscal first-quarter financial results before the markets opened on Wednesday.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Walgreens Boots Alliance Inc. (NASDAQ: WBA | WBA Price Prediction) reported its fiscal first-quarter financial results before the markets opened on Wednesday. The retailer said that it had $1.37 in earnings per share (EPS) and $34.3 billion in revenue, which compared with consensus estimates of $1.41 in EPS and $34.6 billion in revenue. The same period of last year reportedly had $1.46 in EPS and $33.79 billion in revenue.
Overall, net sales saw an increase of 1.6% from the year-ago quarter and an increase of 2.3% on a constant currency basis.
The Retail Pharmacy USA segment had fourth-quarter sales of $26.1 billion, an increase of 1.6% year over year. At the same time, Retail Pharmacy International saw sales of $2.7 billion, a decrease of 5.4%.
Pharmaceutical Wholesale had fourth-quarter sales of $6.0 billion, an increase of 5.2%. On a constant currency basis, comparable sales increased 8.3%, led by emerging markets and the United Kingdom.
The company maintained guidance of roughly flat growth in fiscal 2020 adjusted EPS at constant currency rates, with a range of plus or minus 3%. Consensus estimates are calling for $5.93 in EPS and $139.91 billion in revenue for the full year.
[nativounit]
Stefano Pessina, executive vice chair and chief executive, commented:
We are maintaining our outlook for the year despite a soft first quarter. We are confident our strategic plans are the right ones to drive long-term sustainable growth going forward. In addition, during the quarter we were very satisfied with the progress made in our Transformational Cost Management Program and with the strong cash flow we delivered.
Shares of Walgreens traded down nearly 6% at $55.99 on Wednesday, in a 52-week range of $49.03 to $74.94. The consensus price target is $57.21.
[recirclink id=606035]
[wallst_email_signup]
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
